Acme United Corporation reports a 14% increase in Q1 sales but a 40% decline in net income due to higher costs.
Quiver AI Summary
Acme United Corporation reported a 14% increase in net sales for the first quarter of 2026, totaling $52.3 million compared to $46.0 million during the same period in 2025. Excluding sales from the recent acquisition of My Medic, comparable sales grew by 6%. However, net income fell by 40% to $1.0 million due to higher costs of sales and operating expenses stemming from tariff-related impacts and increased healthcare costs. The company is addressing these challenges by optimizing operations, including relocating to a new facility and enhancing automation. My Medic, acquired earlier this year, is anticipated to boost profitability primarily in the fourth quarter. Additionally, significant sales growth was experienced in both U.S. and European markets, alongside an improved gross margin, despite higher debt levels owing to acquisitions and investments.
Potential Positives
- Net sales for Q1 2026 increased by 14% compared to Q1 2025, indicating strong revenue growth.
- The acquisition of My Medic contributed to sales growth, demonstrating successful integration of new business assets.
- Gross margin improved to 39.7% from 39.0% year-over-year, suggesting better efficiency in production and sales.
- Expansions in retail distribution and improvements in purchasing strategies are expected to strengthen profitability in the future.
Potential Negatives
- Net income decreased by 40% compared to the prior year, significantly impacting the company's profitability.
- Diluted earnings per share fell by 41%, which may raise concerns among investors regarding financial performance.
- The increase in bank debt from $27.2 million to $38.6 million suggests a potential risk related to financial leverage and cash flow management.
FAQ
What were Acme United's net sales for Q1 2026?
Net sales for Acme United in Q1 2026 were $52.3 million, up 14% from $46.0 million in Q1 2025.
How much did Acme United’s net income decrease in Q1 2026?
Net income decreased by 40% to $1.0 million in Q1 2026, compared to $1.7 million in Q1 2025.
What contributed to the sales growth in Q1 2026?
Sales growth in Q1 2026 was driven by increased first aid product sales and the acquisition of My Medic.
What are the expected seasonal trends for My Medic's profitability?
My Medic is expected to generate most of its profitability in the fourth quarter due to its seasonal business model.
What challenges is Acme United facing in its supply chain?
Acme United faces supply chain challenges due to global conflicts, increased costs, and potential product shortages.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$ACU Revenue
$ACU had revenues of $47.5M in Q4 2025. This is an increase of 3.44% from the same period in the prior year.
You can track ACU financials on Quiver Quantitative's ACU stock page.
$ACU Hedge Fund Activity
We have seen 19 institutional investors add shares of $ACU stock to their portfolio, and 34 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JANNEY MONTGOMERY SCOTT LLC removed 16,945 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $760,999
- ADVYZON INVESTMENT MANAGEMENT, LLC added 12,484 shares (+inf%) to their portfolio in Q4 2025, for an estimated $503,230
- QUANTINNO CAPITAL MANAGEMENT LP added 11,100 shares (+inf%) to their portfolio in Q4 2025, for an estimated $447,441
- BLACKROCK, INC. added 9,365 shares (+5.9%) to their portfolio in Q4 2025, for an estimated $377,503
- ROYCE & ASSOCIATES LP removed 8,427 shares (-5.4%) from their portfolio in Q4 2025, for an estimated $339,692
- O'SHAUGHNESSY ASSET MANAGEMENT, LLC removed 7,258 shares (-28.8%) from their portfolio in Q4 2025, for an estimated $292,569
- UBS GROUP AG removed 6,019 shares (-31.9%) from their portfolio in Q4 2025, for an estimated $242,625
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
SHELTON, Conn., April 23, 2026 (GLOBE NEWSWIRE) -- Acme United Corporation (NYSE American: ACU) today announced that net sales for the quarter ended March 31, 2026 were $52.3 million compared to $46.0 million for the quarter ended March 31, 2025, an increase of 14%. Excluding incremental sales resulting from the acquisition of the assets of My Medic on January 15, 2026, comparable sales increased 6%.
Net income was $1.0 million, or $0.24 per diluted share, for the quarter ended March 31, 2026, compared to $1.7 million, or $0.41 per diluted share, for the comparable period last year, a decrease of 40% in net income and 41% diluted earnings per share. This decrease was due to higher cost of sales and increased operating expenses primarily as a result of higher tariff-related costs and investments in enhanced quality assurance protocols at the Med-Nap facility, together with rising employee healthcare expenses. Tariff expenses were recognized during the first quarter as the company sold inventory that had been subject to higher tariff rates imposed in 2025.
The recently acquired My Medic business, which sells tactical, trauma and emergency response products directly to consumers, contributed to sales growth, with minimal impact on earnings in the first quarter. As a direct-to-consumer seasonal business, My Medic is expected to generate the majority of its profitability in the fourth quarter.
Chairman and CEO, Walter C. Johnsen said, “While we experienced higher costs of sales and operating expenses in the first quarter, the impact was magnified due to the seasonality of our business, which traditionally has lower sales in the first quarter. We are actively working to improve profitability. We just moved into our new Spill Magic facility in Tennessee- in the process lowering expenses and providing room to expand; consolidated one of our sites in Canada; and are continuing to install automation throughout our facilities. My Medic, which has annual sales of $19 million, offers many compelling growth and cost saving opportunities. We are expanding My Medic’s retail distribution while also leveraging Acme United’s strong purchasing network to reduce costs, cutting overhead, and consolidating functions. Importantly, the expenses incurred for the enhanced quality assurance protocols at the Med-Nap facility were one-time, non-recurring expenses.”
Mr. Johnsen continued, “We have been proactively purchasing additional inventory in preparation for product shortages and cost increases resulting from the conflict in Iran. To date, we have added approximately $10 million of incremental orders for delivery in the second and third quarters and are carefully evaluating additional purchases.”
Mr. Johnsen concluded, “Acme United has extensive experience with supply chain challenges, and I am confident that our team will address them successfully. I also believe the investments we have been making in expanding Acme United’s business lines, technology, and capacity will continue to strengthen our Company.”
For the first quarter of 2026, net sales in the U.S. segment increased 12% compared to the same period in 2025 due to increased sales of first aid and medical products and additional sales resulting from the acquisition of My Medic.
European net sales for the first quarter of 2026 increased 32% in U.S. dollars and 19% in local currency compared to the first quarter of 2025 due primarily to higher ecommerce sales and additional sales resulting from the acquisition of the line of cutting and sharpening products in Germany on October 1, 2025.
Net sales in Canada for the first quarter of 2026 increased 16% in U.S. dollars and 11% in local currency compared to the same period in 2025 due to higher sales of first aid products.
Gross margin was 39.7% in the first quarter of 2026 versus 39.0% in the comparable period last year.
The Company’s bank debt less cash as of March 31, 2026 was $38.6 million compared to $27.2 million as of March 31, 2025. During the twelve-month period ended March 31, 2026, the Company paid approximately $14.6 million for the acquisition of the assets of My Medic ($18.7 million purchase price less $4.1 million of holdbacks), distributed approximately $2.4 million in dividends on its common stock and purchased the cutting and sharpening line of products in Germany for approximately $1.6 million. Additionally, the Company generated approximately $14.2 million in free cash flow, before the purchase for cash of a new $6.0 million manufacturing and distribution facility in Tennessee in July 2025 to expand the Company’s Spill Magic business.
Conference Call and Webcast Information
Acme United will hold a conference call to discuss its quarterly results, which will be broadcast on Thursday, April 23, 2026, at 12:00 p.m. ET. To listen or participate in a question-and-answer session, dial 877-407-0784
.
International callers may dial 201-689-8560. The confirmation code is 13759878. You may access the live webcast of the conference call through the Investor Relations section of the Company’s website, www.acmeunited.com. A replay may be accessed under Investor Relations, Audio Archives.
About Acme United
ACME UNITED CORPORATION
is a leading worldwide supplier of innovative safety solutions and cutting technology to the school, home, office, hardware, sporting goods and industrial markets. Its leading brands include
First Aid Only
®,
First Aid Central
®,
Physicians
Care
®, Pac-Kit®,
Spill Magic
®,
Westcott
®,
Clauss
®,
DMT
®,
Med-Nap
®,
Elite First Aid
® and
My Medic
®. For more information, visit
www.acmeunited.com
.
| Contact |
| Acme United Corporation |
| Paul G. Driscoll, 203-254-6060 |
| [email protected] |
Forward-Looking Statements
The Company may from time to time make written or oral “forward-looking statements” including statements contained in this report and in other communications by the Company, which are made in good faith pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Such statements are based on our beliefs as well as assumptions made by and information currently available to us. When used in this document, words like “may,” “might,” “will,” “except,” “anticipate,” “believe,” “potential,” and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from our current expectations.
Forward-looking statements in this report, including without limitation, statements related to the Company’s plans, strategies, objectives, expectations, intentions and adequacy of resources, are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties that may impact the Company’s business, operations and financial results.
These risks and uncertainties include, without limitation, the following: (i) changes in the Company’s plans, strategies, objectives, expectations and intentions, which may be made at any time at the discretion of the Company; (ii) the impact of volatility in global economic conditions, including the impact on the Company’s suppliers and customers; (iii) international trade policies of the United States or foreign governments and their impact on demand for our products and our competitive position, including the imposition of new tariffs, changes in existing tariff rates or the threat of any such action; (iv) the continuing adverse impact of inflation, including product costs, and interest rates; (v) potential adverse effects on the Company, its customers, and suppliers resulting from the conflicts in Ukraine and the Middle East; (vi) additional disruptions in the Company’s supply chains, whether caused by pandemics, natural disasters, including trucker shortages, strikes, port closures or otherwise; (vii) labor related costs the Company has and may continue to incur, including costs of acquiring and training new employees and rising wages and benefits; (viii) currency fluctuations; (ix) the Company’s ability to effectively manage its inventory in a rapidly changing business environment; (x) changes in client needs and consumer spending habits; (xi) the impact of competition; (xii) the impact of technological changes including, specifically, the growth of online marketing and sales activity; and (xiii) the Company’s ability to manage its growth effectively, including its ability to successfully integrate any business it might acquire; and (xiv) other risks and uncertainties indicated from time to time in the Company’s filings with the Securities and Exchange Commission.
| ACME UNITED CORPORATION | ||||||
| CONDENSED CONSOLIDATED STATEMENTS OF INCOME | ||||||
| FIRST QUARTER REPORT 2026 | ||||||
| (Unaudited) | ||||||
| Quarter Ended | Quarter Ended | |||||
| Amounts in $000's except per share data | March 31, 2026 | March 31, 2025 | ||||
| Net sales | $ | 52,301 | $ | 45,958 | ||
| Cost of goods sold | 31,516 | 28,041 | ||||
| Gross profit | 20,785 | 17,917 | ||||
| Selling, general and administrative expenses | 19,039 | 15,491 | ||||
| Operating income | 1,746 | 2,426 | ||||
| Net interest expense | 485 | 397 | ||||
| Other expense (income), net | 17 | (90 | ) | |||
| Income before income tax expense | 1,244 | 2,119 | ||||
| Income tax expense | 259 | 466 | ||||
| Net income | $ | 985 | $ | 1,653 | ||
| Shares outstanding - basic | 3,808 | 3,754 | ||||
| Shares outstanding - diluted | 4,156 | 4,065 | ||||
| Earnings per share - basic | $ | 0.26 | $ | 0.44 | ||
| Earnings per share - diluted | 0.24 | 0.41 | ||||
| ACME UNITED CORPORATION | |||||
| CONDENSED CONSOLIDATED BALANCE SHEETS | |||||
| FIRST QUARTER REPORT 2026 | |||||
| (Unaudited) | |||||
| Amounts in $000's | |||||
| March 31, 2026 | March 31, 2025 | ||||
| Assets | |||||
| Current assets: | |||||
| Cash and cash equivalents | $ | 4,196 | $ | 3,446 | |
| Accounts receivable, net | 33,511 | 30,814 | |||
| Inventories | 63,386 | 57,274 | |||
| Prepaid expenses and other current assets | 4,518 | 5,311 | |||
| Total current assets | 105,611 | 96,845 | |||
| Property, plant and equipment, net | 39,295 | 32,153 | |||
| Operating lease right of use asset | 6,408 | 4,443 | |||
| Intangible assets, less accumulated amortization | 34,021 | 19,690 | |||
| Goodwill | 9,908 | 9,908 | |||
| Total assets | $ | 195,243 | $ | 163,039 | |
| Liabilities and stockholders' equity | |||||
| Current liabilities: | |||||
| Accounts payable | $ | 7,654 | $ | 7,433 | |
| Operating lease liability - short term | 1,373 | 1,533 | |||
| Mortgage payable - short term | 458 | 441 | |||
| Other current liabilities | 13,619 | 10,662 | |||
| Total current liabilities | 23,104 | 20,069 | |||
| Long-term debt | 33,030 | 20,428 | |||
| Mortgage payable - long term | 9,362 | 9,769 | |||
| Operating lease liability - long term | 5,176 | 3,012 | |||
| Other non-current liabilities | 7,843 | 1,480 | |||
| Total liabilities | 78,516 | 54,758 | |||
| Total stockholders' equity | 116,727 | 108,281 | |||
| Total liabilities and stockholders' equity | $ | 195,243 | $ | 163,039 | |